Viewing Study NCT04515394


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2025-12-28 @ 12:01 AM
Study NCT ID: NCT04515394
Status: TERMINATED
Last Update Posted: 2022-12-22
First Post: 2020-08-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
Sponsor: EMD Serono Research & Development Institute, Inc.
Organization: